MedX Health Corp
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDXHF research report →
Companymedxhealth.com
MedX Health Corp, a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market; and SIAMETRICS, SIMSYS, and MoleMate, which creates real-time images for physicians and dermatologists to evaluate various types of moles or lesions within seconds. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment.
- CEO
- John Gevisser
- IPO
- 2008
- Employees
- 312
- HQ
- Mississauga, ON, CA
Price Chart
Valuation
- Market Cap
- $14.43M
- P/E
- -3.17
- P/S
- 41.97
- P/B
- -2.04
- EV/EBITDA
- -6.58
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -13.77%
- Op Margin
- -903.70%
- Net Margin
- -1325.91%
- ROE
- 65.95%
- ROIC
- 242.37%
Growth & Income
- Revenue
- $472.88K · -3.43%
- Net Income
- $-6,285,302 · -72.06%
- EPS
- $-0.02 · -54.01%
- Op Income
- $-4,288,562
- FCF YoY
- -48.52%
Performance & Tape
- 52W High
- $0.05
- 52W Low
- $0.00
- 50D MA
- $0.04
- 200D MA
- $0.02
- Beta
- 8.51
- Avg Volume
- 4.78K
Get TickerSpark's AI analysis on MDXHF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MDXHF Coverage
We haven't published any research on MDXHF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MDXHF Report →